Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
02/2005
02/03/2005WO2004031722A3 Identification of a polypeptide antagonist to the peripheral-type benzodiazepine receptor (pbr)
02/03/2005WO2004031311A3 Combinatorial screening/testing apparatus and method
02/03/2005WO2004016777A8 Genetically modified non-human mammal cells, procedure for their production and use in toxicity tests
02/03/2005WO2004002400A3 A method for screening a candidate substance as a potential drug for the treatment of malaria
02/03/2005WO2004001420A8 Method and reagent for specifically identifying and quantifying one or more proteins in a sample
02/03/2005WO2004000721A3 Recirculating fluidic network and methods for using the same
02/03/2005WO2003096988A3 Tr4/tr2 response elements
02/03/2005WO2003095624B1 Liver inflammation predictive genes
02/03/2005WO2003094859A3 Epha2 monoclonal antibodies and methods of use thereof
02/03/2005WO2003093788A3 Test strip and method for determining concentration of creatinine in a body fluid
02/03/2005WO2003090515A3 Systems and methods for detection of nuclear receptor function using reporter enzyme mutant complementation
02/03/2005WO2003087412A3 Mutation detection and identification
02/03/2005WO2003081250A8 Novel compositions and methods in cancer associated with altered expression of prlr
02/03/2005WO2003064620A3 Hepsin substrates and prodrugs
02/03/2005WO2003062390A3 Compositions and methods for the modulation of sphingolipid metabolism and/or signaling
02/03/2005WO2003040317A8 Lung cancer therapeutics and diagnostics
02/03/2005WO2003039342A3 Methods and compositions to treat pain and painful disorders using 577, 20739 or 57145
02/03/2005WO2002102235A3 Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
02/03/2005WO2002092837A3 Nucleic and molecule associated with prostate cancer and melanoma immunodetection and immunotherapy
02/03/2005US20050027482 Method for estimating the quality of wood chips
02/03/2005US20050027463 System and methods for processing analyte sensor data
02/03/2005US20050027462 System and methods for processing analyte sensor data
02/03/2005US20050027461 Methods for evaluating oligonucleotide probe sequences
02/03/2005US20050027460 Method, program product and apparatus for discovering functionally similar gene expression profiles
02/03/2005US20050027459 Detection biological warfare agent; nucleotide sequences; incubation; amplification; calssification
02/03/2005US20050027458 Quantum mechanics based method for scoring protein-ligand interactions
02/03/2005US20050027184 Apparatus and method to measure platelet contractility
02/03/2005US20050027181 System and methods for processing analyte sensor data
02/03/2005US20050027180 System and methods for processing analyte sensor data
02/03/2005US20050027179 formed from hexose subunits linked via glycosides; improved tensile strength per denier; cotton-like properties; liquid crystals; for continuous year-round production
02/03/2005US20050027177 Real time self-adjusting calibration algorithm
02/03/2005US20050027114 Methods and materials relating to cd84-like polypeptides and polynucleotides
02/03/2005US20050027108 Expression vector comprising nucleotide sequences coding cardiovascular system associated protein kinases for use in identifying modulators to treat and prevent cardiovascular and cell proliferative disorders
02/03/2005US20050027106 Monoclonal antibodies for use in diagnosis, prevention, classification and treatment of cell proliferative disorders
02/03/2005US20050027104 Antibodies for use in diagnosis, prevention and treatment of autoimmune disease
02/03/2005US20050027103 Matrix protein for use diagnosis, treatment, and prevention of viral infections, cell proliferative and neurological disorders
02/03/2005US20050027100 Membrane anchoring onto crosslinked polyacrylamide; biosensors; automatic peptide/protein synthesis
02/03/2005US20050026878 Steroid modulators in the treatment of peripheral nerve sheath tumors
02/03/2005US20050026866 Detecting or treating mammalian tumor cells; tissue-targeted therapy; genetic engineered Bordetella pertussis; biodrugs
02/03/2005US20050026833 PSP-94: use for treatment of hypercalcemia and bone metastasis
02/03/2005US20050026826 Feline proinsulin, insulin and constituent peptides
02/03/2005US20050026824 Method for treating autoimmune diseases and screening method for preventive or therapeutic agent for the same
02/03/2005US20050026814 Diagnosis and treatment of human kidney diseases
02/03/2005US20050026346 Device for the manipulation of limited quantities of liquids
02/03/2005US20050026306 Apparatus for generating feature data associated with user-specified computer generated search constructs; biopolymer modeling
02/03/2005US20050026305 Aminodextran compositions and conjugates and method of making and using them
02/03/2005US20050026304 Biochips comprising polynucleotide conjugated nanostructures for use in isolation of preferential biolpolymers
02/03/2005US20050026302 Combining transmittance detection and chromatographic strip techniques providing a simple, easy, sensitive, accurate, fast and inexpensive way to quantitate analytes in biological fluid
02/03/2005US20050026298 Dye solutions for use in methods to detect the prior evaporation of anhydrous ammonia and the production of illicit drugs
02/03/2005US20050026297 Kits and methods for preparing gell samples optmimized for dual staining
02/03/2005US20050026296 Using lipid profiles to diagnose infection, cell proliferative, respiratory, blood and inflammatory disease
02/03/2005US20050026294 Apparatus which monitors the permeation of a liquid or gas substance through materials and fabrics; liquid permeation testing
02/03/2005US20050026292 GLYT1 conditional knock-out mice
02/03/2005US20050026285 Identifying modulators of kappa recognition component ("KRC") activity for use in prevention and treatment of autoimmune and cell proliferative disorders
02/03/2005US20050026284 Nuclease inhibitor cocktail
02/03/2005US20050026283 Using electric field modification to transfer components across cell barriers; organelle transfer; in vitro fertility
02/03/2005US20050026278 RNA interference mediating small RNA molecules
02/03/2005US20050026277 Device for thermo-dependent chain reaction amplification of target nucleic acid sequences, measured in real-time
02/03/2005US20050026251 Netrin receptor protein for use in identification of modulator for use in treatment and prevention of infection, nervous system, autoimmune, inflammatory, psycological and reproductive disorders
02/03/2005US20050026241 Method and device for determining distribution of glycation of erythrocytic membranes
02/03/2005US20050026240 Reagent composition for the analysis of residual white blood cells in leuko-reduced blood banking products
02/03/2005US20050026239 Limulus amebocyte lysate (LAL)-based gel clot assay for detection of poisons in solutions
02/03/2005US20050026238 System and method for detecting particles
02/03/2005US20050026236 PDE 10 cell-based assay and sequences
02/03/2005US20050026235 Fluorescent phospholipase assays and compositions
02/03/2005US20050026234 Chimeric phosphorylation indicator comprising fluorescent protein and phosphoaminoacid binding domain for use as diagnostic indicator of kinase activity in different compartments of organelles
02/03/2005US20050026233 Using bioassay for loss-of-function mutations in protein kinase (LKB1) as diagnostic tool in detection of cell proliferative disorders; AMP-activated protein kinase (AMPK) and treatment of diabetic, cardiovascular and dietetic disorders
02/03/2005US20050026232 Monoclonal antibody which preferentially binds leukocyte common antigen-related molecule phosphatase (LAR) for use in diagnosis, prevention and treatment of cell proliferative disorders
02/03/2005US20050026231 Antibodies; probes; gene expression; kits; vaccines
02/03/2005US20050026230 Method and apparatus for cell recovery
02/03/2005US20050026229 Cell line for use in generating monoclonal antibodies specific for prostate stem cell antigen (PSCA) for use in diagnosis of cell proliferative disorders; immunodiagnostics
02/03/2005US20050026228 Using concentration of receptor protein tyrosine kinase polypeptide/adaptor complex as diagnostic indicator of cell proliferative disorders; turmor diagnosis and treatment
02/03/2005US20050026227 Method for assaying protein nitrosylation
02/03/2005US20050026226 Serum Paraoxonase
02/03/2005US20050026225 Urogenital polypeptide for use in diagnosis of renal disorders
02/03/2005US20050026224 Methods and compositions for modulating G-protein coupled receptor 54
02/03/2005US20050026223 Identifying modulators which bind hormone receptors, enhance bone characteristics and treat bone disorders
02/03/2005US20050026219 Using modified sensors comprising phosphotyrosine receptor bind site to identify modulators of kinase activity; high throughput assay
02/03/2005US20050026218 Expression vector comprising nucleotide sequences coding type IV secretion system proteins (T4SS) for use in identifying modulator for treatment of rickettsia infection
02/03/2005US20050026217 Protein structure prediction device, protein structure prediction method, program, and recording medium
02/03/2005US20050026215 Method for the prediction of an epitope
02/03/2005US20050026214 Method of identifying glycosyl transferase binding compounds
02/03/2005US20050026207 CACNA1G polynucleotide, polypeptide and methods of use therefor
02/03/2005US20050026203 Method and system for providing a probe array chip design database
02/03/2005US20050026202 Electronic systems and component devices for macroscopic and microscopic molecular biological reaction, analyses, and diagnostics
02/03/2005US20050026200 Method for error detection and increased confidence of sample decoding
02/03/2005US20050026199 Method for identifying biomarkers using Fractal Genomics Modeling
02/03/2005US20050026198 Method of selecting an active oligonucleotide predictive model
02/03/2005US20050026197 Using nucleic acid stains to identify and discriminate between populations of erythrocytes; in vivo testing for chromosomal damage
02/03/2005US20050026196 Prognostic marker for prostate cancer and methods and kits for using same
02/03/2005US20050026195 Spotter provided with spot pattern encryption function and detection device coping with spot pattern encryption
02/03/2005US20050026194 Using overexpression of relaxin-3 and somatostatin and angiotensin-like peptide receptor (SALPR) as diagnostic indicator of cell proliferative disorders
02/03/2005US20050026193 Using nuclease protection to identify preferential nucleotide sequences
02/03/2005US20050026189 Designing vector for use as tool in preventing aberrant cell proliferation; antiproliferfative agents; tissue targeted therapy
02/03/2005US20050026186 Method for evaluating an inclination of a subject to lung cancer
02/03/2005US20050026183 Using methylation patterns of guanine and cytosine dinucleotides as a diagnostic and/or prognostic indicator of cell proliferfative disorders; genomic imprinting control regions (ICRs)
02/03/2005US20050026182 Human CDNAS and proteins and uses thereof
02/03/2005US20050026180 Direct multiplex characterization of genomic DNA
02/03/2005US20050026178 Allosteric probes and methods
02/03/2005US20050026176 DNA probe design device and information processing method for DNA probe design